3-187236125-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_139125.4(MASP1):c.1746G>A(p.Pro582Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00712 in 1,613,866 control chromosomes in the GnomAD database, including 66 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0051 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0073 ( 65 hom. )
Consequence
MASP1
NM_139125.4 synonymous
NM_139125.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.20
Genes affected
MASP1 (HGNC:6901): (MBL associated serine protease 1) This gene encodes a serine protease that functions as a component of the lectin pathway of complement activation. The complement pathway plays an essential role in the innate and adaptive immune response. The encoded protein is synthesized as a zymogen and is activated when it complexes with the pathogen recognition molecules of lectin pathway, the mannose-binding lectin and the ficolins. This protein is not directly involved in complement activation but may play a role as an amplifier of complement activation by cleaving complement C2 or by activating another complement serine protease, MASP-2. The encoded protein is also able to cleave fibrinogen and factor XIII and may may be involved in coagulation. A splice variant of this gene which lacks the serine protease domain functions as an inhibitor of the complement pathway. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 3-187236125-C-T is Benign according to our data. Variant chr3-187236125-C-T is described in ClinVar as [Benign]. Clinvar id is 285006.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-187236125-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.2 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00513 (781/152306) while in subpopulation SAS AF= 0.0197 (95/4824). AF 95% confidence interval is 0.0165. There are 1 homozygotes in gnomad4. There are 403 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 65 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MASP1 | NM_139125.4 | c.1746G>A | p.Pro582Pro | synonymous_variant | Exon 11 of 11 | ENST00000296280.11 | NP_624302.1 | |
MASP1 | NM_001879.6 | c.1303+5356G>A | intron_variant | Intron 10 of 15 | ENST00000337774.10 | NP_001870.3 | ||
MASP1 | NR_033519.2 | n.1619G>A | non_coding_transcript_exon_variant | Exon 10 of 10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MASP1 | ENST00000296280.11 | c.1746G>A | p.Pro582Pro | synonymous_variant | Exon 11 of 11 | 1 | NM_139125.4 | ENSP00000296280.7 | ||
MASP1 | ENST00000337774.10 | c.1303+5356G>A | intron_variant | Intron 10 of 15 | 1 | NM_001879.6 | ENSP00000336792.5 |
Frequencies
GnomAD3 genomes AF: 0.00514 AC: 782AN: 152188Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
782
AN:
152188
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00673 AC: 1683AN: 250114Hom.: 13 AF XY: 0.00728 AC XY: 987AN XY: 135564
GnomAD3 exomes
AF:
AC:
1683
AN:
250114
Hom.:
AF XY:
AC XY:
987
AN XY:
135564
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00733 AC: 10716AN: 1461560Hom.: 65 Cov.: 80 AF XY: 0.00761 AC XY: 5532AN XY: 727116
GnomAD4 exome
AF:
AC:
10716
AN:
1461560
Hom.:
Cov.:
80
AF XY:
AC XY:
5532
AN XY:
727116
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00513 AC: 781AN: 152306Hom.: 1 Cov.: 33 AF XY: 0.00541 AC XY: 403AN XY: 74474
GnomAD4 genome
AF:
AC:
781
AN:
152306
Hom.:
Cov.:
33
AF XY:
AC XY:
403
AN XY:
74474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
57
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
May 02, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not specified Benign:1
Nov 25, 2015
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
3MC syndrome 1 Benign:1
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at